These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4094427)

  • 1. Chemotherapy in combination with hormonal therapy in breast cancer. An update. Proceedings of an international symposium. S. Terenzo di Lerici, La Spezia, Italy, 24-25 September 1983.
    J Steroid Biochem; 1985 Dec; 23(6B):1093-183. PubMed ID: 4094427
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of cancer of the breast in the metastatic phase].
    Clavel M
    Pathol Biol (Paris); 1989 Feb; 37(2):137-9. PubMed ID: 2652064
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day].
    Bonneterre J; Coppens H; Mauriac L; Rouesse J; Fargeot P; Metz R; Armand JP; Mathieu A; Tubiana M; Cappelaere P
    Acta Clin Belg Suppl; 1986; 11():41-8. PubMed ID: 3521171
    [No Abstract]   [Full Text] [Related]  

  • 4. A prognostic table to guide practitioners advising patients on adjuvant systemic therapy in early breast cancer.
    Stotter A
    Eur J Surg Oncol; 1999 Aug; 25(4):341-3. PubMed ID: 10419700
    [No Abstract]   [Full Text] [Related]  

  • 5. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
    Kaufmann M; Hortobagyi GN; Goldhirsch A; Scholl S; Makris A; Valagussa P; Blohmer JU; Eiermann W; Jackesz R; Jonat W; Lebeau A; Loibl S; Miller W; Seeber S; Semiglazov V; Smith R; Souchon R; Stearns V; Untch M; von Minckwitz G
    J Clin Oncol; 2006 Apr; 24(12):1940-9. PubMed ID: 16622270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy and endocrine therapy in metastatic disease.
    Pritchard KI
    Curr Opin Oncol; 1989 Dec; 1(2):324-32. PubMed ID: 2489975
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings of an international workshop on alpha-fetoprotein: new trends and perspectives. San Terenzo di Lerici (La Spezia), October 20-21, 1989.
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):1-137. PubMed ID: 2480403
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant systemic therapy in primary breast cancer.
    Mouridsen HT; Palshof T
    Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy].
    Jiang Z; Song S; Liu X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):420-2. PubMed ID: 11810777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian ablation as adjuvant therapy for early-stage breast cancer.
    Pritchard KI
    Cancer Treat Res; 1998; 94():158-80. PubMed ID: 9587687
    [No Abstract]   [Full Text] [Related]  

  • 11. Endocrine therapy for early breast cancer.
    Hussain SA; Williams S; Stevens A; Rea DW
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):877-88. PubMed ID: 15485321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormone therapy of metastasizing breast carcinoma].
    Hagen MF; Thürlimann B
    Ther Umsch; 1996 Nov; 53(11):820-8. PubMed ID: 8984687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal therapy of breast cancer: state of the art.
    Murphy B; Muss HB
    Oncology (Williston Park); 1997 May; 11(5 Suppl 4):7-13. PubMed ID: 9165500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of the breast].
    Battelli T; Manocchi P; Guistini L; Mattioli R; Ginnetti A
    Minerva Med; 1984 Feb; 75(6):227-33. PubMed ID: 6231491
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
    Heuson JC; Paridaens R
    Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
    [No Abstract]   [Full Text] [Related]  

  • 16. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy.
    Thomas S; Munster PN
    Cancer Lett; 2009 Aug; 280(2):184-91. PubMed ID: 19185986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.
    ; Basser RL; O'Neill A; Martinelli G; Green MD; Peccatori F; Cinieri S; Coates AS; Gelber RD; Aebi S; Castiglione-Gertsch M; Viale G; Price KN; Goldhirsch A
    J Clin Oncol; 2006 Jan; 24(3):370-8. PubMed ID: 16421418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status of adjuvant endocrine therapy for hormone responsive breast cancer].
    Ikeda T; Jinno H; Masamura S; Matsui A; Tajima G; Hohjoh T; Tokura H; Mitsui Y; Asaga S; Muto T; Fujiwara K; Kitajima M
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):902-8. PubMed ID: 11478138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant for breast cancer chemo-endocrine therapy].
    Taguchi T
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):453-67. PubMed ID: 9530350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up.
    Hubay CA; Gordon NH; Crowe JP; Guyton SP; Pearson OH; Marshall JS; Mansour EG; Hermann RE; Jones JC; Flynn WJ
    Surgery; 1984 Jul; 96(1):61-72. PubMed ID: 6740497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.